Chimeric Co-Stimulatory Molecules That Selectively Act Through CD28 or CTLA-4 on Human T Cells

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m205808200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells

PLoS ONE
Multidisciplinary
2013English

T-Cell Co-Stimulatory Molecules: Their Role in Allergic Immune Reactions

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2007English

Activated Human B Lymphocytes Express Three CTLA-4 Counterreceptors That Costimulate T-Cell Activation.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

CD81 and CD28 Costimulate T Cells Through Distinct Pathways

Journal of Immunology
AllergyImmunology
2000English

Expression of Adhesion Molecules and CD28 on T Lymphocytes During Human Immunodeficiency Virus Infection

Clinical Diagnostic Laboratory Immunology
1998English

Anti–CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers—Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

Human Mucosal CD4+ T Cells but Not Blood CD4+ T Cells Respond Vigorously Towards CD28 Engagement

Clinical and Experimental Immunology
AllergyImmunology
2012English

Chimeric Antigen Receptor T-Cells

Cancer Journal
Cancer ResearchOncology
2015English

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells

Journal of Immunology
AllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy